Naturstoff-basierte Arzneimittelentwicklung

Drug Discovery
& Development

Drug Discovery & Development

The term “poststantibiotic era” was coined about three decades ago when available antibiotics gradually ceased to be effective on account of the emergence of multidrug resistance in infectious microorganisms. It is a fact that human pathogens are developing increasing resistance to a broad range of available antimicrobials, thus putting into doubt the success of treatment with conventional antibiotics. It is for this very reason that the BioΦytoMedical ScientificTeam is working on the development of drugs based on natural products for the treatment of infections.

Dr. rer. nat. Klaus Biehler und Prof. Dr. med. Uwe Frank

Nachgefragt: Pflanzliche Anti-Infektiva (Pharmazeutische Zeitung)